This public procurement record has 5 releases in its history.

Tender

30 Sep 2026 at 14:30

Planning

22 Jul 2026 at 12:36

PlanningUpdate

15 Jul 2026 at 09:55

PlanningUpdate

23 Apr 2026 at 08:26

Planning

23 Apr 2026 at 08:14

Summary of the contracting process

NHS England is buying lenvatinib, a pharmaceutical medicine, through a national framework for supply to NHS pharmacy purchasing points. The procurement is managed by NHS England’s Medicines Procurement and Supply Chain team. Delivery is across the North East, North West, East Midlands, West Midlands, East of England, South East and South West of England. The requirement is for suppliers able to provide the medicine to the participating NHS purchasing points; the framework documents describe the detailed operating requirements and product listing.

NHS England invited offers through an open procedure. This is a framework agreement with further competition when individual contracts are awarded. The requirement is divided into three regional lots: CESW, NWLN and LSNE. Enquiries were due by 23 October 2026 at 13:00; tenders were due by 30 October 2026 at 14:00. The evaluation period was due to end on 25 November 2026. The stated framework periods begin on 1 June 2027: 20 months for Lot 1, 16 months for Lot 2 and 12 months for Lot 3, with extensions at the authority’s discretion of up to 24 months. The estimated value for Lot 1 is £35,833,000 excluding VAT (£42,999,600 including VAT). Price is not the only award criterion; the published weighting is 100%.

This opportunity is for pharmaceutical suppliers able to supply lenvatinib to NHS purchasing points across several English regions. Small and medium-sized businesses are identified as suitable for Lot 1. Suppliers should be prepared to meet the framework’s quality assurance and quality-control requirements and to complete the procurement questionnaire and offer schedules. The purchasing model is a national framework, with competition reopened for subsequent awards, so bidders need the capacity to support NHS pharmacy buyers under the framework arrangements as well as to compete for later requirements. The supplied information does not describe specific manufacturing, licensing, or prior-experience thresholds, so the framework documentation is the source for assessing those requirements.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Lenvatinib

Notice Description

Project title: NHS National Framework for Lenvatinib Offer reference number: CM/TNS/26/5751 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5751 Lenvatinib Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months) Lot 2 NWLN: 01/06/2027 to 30/09/2028 (16 months) Lot 3 LSNE: 01/06/2027 to 31/05/2028 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

Lot 1

Renewal: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

Planning Information

NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecule(s) that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06891a
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/092421-2026
Current Stage
Tender
All Stages
Planning, Tender

Procurement Classification

Notice Type
UK4 - Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£35,833,000 £10M-£100M
Lots Value
£35,833,000 £10M-£100M
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
30 Sep 20263 weeks ago
Submission Deadline
30 Oct 20265 days to go
Future Notice Date
30 Sep 2026Expired
Award Date
Not specified
Contract Period
1 Jun 2027 - 31 Jan 2029 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)

Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...